Laurie Toich, Assistant Editor

Low testosterone found to increase the prevalence of chronic diseases among prostate cancer survivors.

Hypogonadism associated with increased chance of high cholesterol, hypertension, erectile dysfunction, and diabetes.

Top news of the day from across the healthcare landscape.

CTL019 is an investigational chimeric antigen receptor T cell therapy.

Novel treatment may prevent patients with type 1 diabetes from developing end-stage renal disease.

Frequent intake of coffee or herbal tea was found to lower the risk of liver stiffness.

Symptoms of neonatal discontinuation syndrome may result in preterm birth rather than antidepressant use.

Replacing saturated fats with polyunsaturated vegetable oil reduced heart disease risk by 30%.

A dose of insulin 3 hours after eating may prevent blood vessel damage among patients with type 1 diabetes.

Top news of the day from across the healthcare landscape.

Better Care Reconciliation Act would structure subsidies differently than the American Health Care Act.

Lowering systolic blood pressure can reduce the risk of cardiovascular disease and mortality.

Study suggests importance for individuals to get yearly flu shots.

Patients with type 2 diabetes who do not take insulin may not require fingerstick testing.

Top news of the day from across the healthcare landscape.

The FDA has created a list of off-patent drugs with no generics and plans to expedite drug approvals.

Nilotinib (Tasigna) may lead to treatment-free remission among certain patients with chronic myeloid leukemia.

Type 2 diabetes could result from beta cells becoming immature and not properly functioning.

Erelzi (etanercept) indicated to treat multiple inflammatory conditions.

High body mass index found to increase severity of hot flashes.

Top news of the day from across the healthcare landscape.

Drug Competition Action Plan seeks to advance use of generic drugs to lower costs.

Drug delivery strategy blocks pain in nerve cells to provide long-lasting treatment.

SomnaPatch may identify obstructive sleep apnea without observation in a clinic.

C1 esterase inhibitor (Haegarda) may prevent swelling attacks associated with hereditary angioedema.

Betrixaban (Bevyxxa) approved to prevent venous thromboembolism among hospitalized patients.

Getting too much or too little sleep can elevate the risk of cancer.

Even adolescents were able to administer naloxone HCl (Narcan) nasal spray in an emergency situation.

Low-grade inflammation from sleep disturbance may increase risk of dementia and cancer.

Top news of the day from across the healthcare landscape.